1-7 of 7
Fernando Vargas Madueno
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab plus lenalidomide (R²) versus standard therapies in follicular lymphoma: A systematic review and meta-analysis of randomized controlled trials

Free
Abat Khan, Name: Iftikhar Khan, Moosa Mubarika, Maheen Shaharyar, Sara Aleem, Umama Alam, Hooria Aiman, Amna Binte Naeem, Hareem Saleem, Muhammad Nouman, Ayesha Imran Butt, Hafiz Muhammad Haris, Fajar Nadeem, Zunaira Maham Fatima, Muhammad Junaid Azhar, Hira Habib, Asim Ahmad Khan, Carlos H Silva Rondon, Fernando Vargas Madueno, Jose D. Sandoval-Sus
Journal: Blood
Blood (2025) 146 (Supplement 1): 1828.
https://doi.org/10.1182/blood-2025-1828
Published: 2025
Journal Articles

Trial in progress: A Phase I/II study to investigate the combination of LP-118, ponatinib, vincristine and dexamethasone (LPVd regimen) in relapsed/refractory T-ALL/lbl

Free
Caner Saygin, Anand Patel, Hannah Levavi, Kristen O'Dwyer, Meixiao Long, Fernando Vargas Madueno, Chenyu Lin, Theodore Karrison, Howard Weiner, Adam Duvall, Satyajit Kosuri, Rafael Madero-Marroquin, Gregory Roloff, Michael Drazer, Michael Thirman, Richard Larson, Olatoyosi Odenike, L. Evan Reddick, Yu Chen, Stephen Anthony, Wendy Stock
Journal: Blood
Blood (2025) 146 (Supplement 1): 5136.
https://doi.org/10.1182/blood-2025-5136
Published: 2025
Journal Articles

Outpatient administration of epcoritamab monotherapy for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL): Results from EPCORE NHL-6 by race and ethnicity

Free
Adelba Torres, Rakhee Vaidya, Fernando Vargas Madueno, Sami Ibrahimi, Seema Naik, Mitul Gandhi, Julie Haydu, Bradley Lash, Mark Fesler, John Hrom, Eric Lee, Suchitra Sundaram, Kristin Conte, Kojo Osei-Bonsu, Yang Bai, Christian Eskelund, Alexander Boardman, Ralph Vincent Boccia, Christina Lee, David Andorsky, Jeff Sharman
Journal: Blood
Blood (2025) 146 (Supplement 1): 1959.
https://doi.org/10.1182/blood-2025-1959
Published: 2025
Journal Articles

Impact of adenovirus infection on the long-term cardiovascular and other outcomes following CAR T-cell therapy: A propensity-matched cohort study

Free
Aakriti Adhikari, Abat Khan, Abdul Wali Khan, Carlos H Silva Rondon, Fernando Vargas Madueno, Jose D. Sandoval-Sus, Furha Cossor
Journal: Blood
Blood (2025) 146 (Supplement 1): 7683.
https://doi.org/10.1182/blood-2025-7683
Published: 2025
Journal Articles

Glofitamab in Combination with Rituximab Plus Ifosfamide, Carboplatin, and Etoposide Shows Favorable Efficacy and Manageable Safety in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Eligible for Stem Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: Results from a Phase Ib Study

Free
Catherine S. Diefenbach, Paolo F. Caimi, Nakhle S Saba, Fernando Vargas Madueno, Mehdi Hamadani, Luis E. Fayad, Peter A. Riedell, Andrew Gillis-Smith, Stephen Simko, Victor Orellana-Noia, Maria Filippou-Frye, Amy V. Kapp, James Relf, Linda Lundberg, Lauren C. Pinter-Brown
Journal: Blood
Blood (2024) 144 (Supplement 1): 987.
https://doi.org/10.1182/blood-2024-198452
Published: 2024
Journal Articles

Incidence of Secondary Malignancy after Treatment with Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor T-Cell Therapies

Free
Can Jones, Amneh A Fares, Diana Martinez, Jennifer M Logue, Carlos Silva Rondon, Fernando Vargas Madueno, Nina Nguyen, Hugo Francisco Fernandez, Julio C. Chavez, Jose Sandoval-Sus
Journal: Blood
Blood (2024) 144 (Supplement 1): 7241.
https://doi.org/10.1182/blood-2024-206293
Published: 2024
Journal Articles

Exclusion of Patients Living with Chronic Viral Infections and Underrepresentation of Ethnic Minorities in Diffuse Large B-Cell Lymphoma Clinical Trials

Free
Stephanie Boisclair, MD, Richie Uba, PharmD, Amanda Brahim, PharmD, Fernando Vargas Madueno, MD, Julio C. Chavez, MD, Jose Sandoval-Sus, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-143226
Published: 2020